drugset

drugset / Trial / NCT00311493

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

NCT00311493 ↗

Phase 4 Completed 179 enrolled Novartis Novartis Vaccines · collab

RandomizedFactorialOpen-labelPrevention

Summary

The purpose of this study it is to evalutate the persistence of antibodies after a booster immunisation with a TBE vaccine for adults

Timeline

Start: 2006-02
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tick-Borne Encephalitis vaccine	Vaccine	—	—

Indications